Ma. Frenkel et al., DYSPLASIA OF BONE-MARROW MEGAKARYOCYTES IN ACUTE MYELODISPLASTIC LEUKEMIA - MORPHOLOGICAL, CYTOCHEMICAL AND CYTOGENETIC DATA, Eksperimental'naa onkologia, 18(3), 1996, pp. 262-267
Bone marrow megakaryocyte patterns and blood platelet counts in 87 AML
patients have been studied. The megakaryocyte number was increased in
16.1% of cases, while in 17.2% of cases it was normal. These indices
were sharply decreased in remaining patients. In fourteen cases no meg
akaryocytes were detected. Dysplasia of megakaryocytes was revealed in
nearly a half of the cases investigated. As a rule, megakaryocyte pro
duction was ineffective: 93% of patients had thrombocytopenia. Increas
ed megakaryocyte numbers were comparatively common and associated with
MO and M4 FAB variants. Megakaryocytosis was observed in each of the
five patients with 3q21 and/or 3q26 abnormalities and was significantl
y less common in the cases with other karyotype changes. The frequency
of the (8; 21)(q22; q22) translocation was significantly lower in pat
ients with dysplasia of megakaryocytes than without it. Increased mega
karyocyte numbers did not correlate with a dysplastic pattern of granu
locytic and erythroid precursors in bone marrow. Marked megakaryocytos
is and high blood platelet level (more than 400 x 10(9)/L) were reveal
ed in four of 87 patients. In two of them abnormalities of both 3q21 a
nd 3q26 were found, one patient had monosomy 7 only and in one case no
rmal karyotype was detected. Possible mechanisms of megakaryocytic dys
plasia in AML are discussed.